← Haleon plc

Annual Trend FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Net Income — — $1.1b $1.0b $1.4b $1.7b
Net Income From Continuing Operations — — $1.1b $1.1b $1.5b $1.7b
Depreciation of property, plant and equipment and right of use assets $215.0m $174.0m $180.0m $201.0m $225.0m $240.0m
Depreciation and amortization $13.4m $13.9m $287.0m $60.5m $60.0m $59.2m
Amortization of debt issuance costs $798k $1.1m — $1.6m $1.7m $2.4m
Amortization and release of related party liability $0 $0 — ($4.1m) ($5.9m) $0
Amortization Cash Flow — — $107.0m $108.0m $99.0m $120.0m
Deferred income taxes ($3.0m) $9.4m — ($7.0m) ($1.2m) ($17.4m)
Deferred tax liability on acquisition — — — $0 $0 $6.5m
Deferred Tax — — $499.0m $517.0m $435.0m $472.0m
Adjustments For Share-Based Payments — — — $76.0m $102.0m $86.0m
Impairment and assets written off, net of reversals $88.0m $1.0m $143.0m $200.0m $192.0m $47.0m
Share-based incentive plan expense — — $15.0m $76.0m $102.0m $86.0m
Loss on impairment of goodwill $0 $0 — $0 $5.0m $152.0m
Loss on impairment of right of use assets — — — $3.6m $0 $0
Adjustments For Income Tax Expense — $197.0m $499.0m $517.0m $435.0m $472.0m
Loss on extinguishment of debt $0 $2.3m — $0 $0 $24.4m
Loss on disposal of equipment $0 $52k — $62k $112k $0
Operating lease liabilities $0 $0 — ($2.6m) ($2.7m) ($3.0m)
Additional Financial Items
Adjustments For Current Tax Of Prior Period — ($50.0m) $25.0m ($31.0m) ($62.0m) ($20.0m)
Adjustments For Decrease Increase In Trade Account Receivable — $14.0m ($85.0m) $38.0m ($312.0m) ($65.0m)
Adjustments For Gain Loss On Disposal Of Investments In Subsidiaries Joint Ventures And Associates — — — — $121.0m —
Adjustments For Increase Decrease In Trade Account Payable — $41.0m $387.0m $112.0m $158.0m $125.0m
Goodwill — $8.2b $8.4b $8.3b $8.2b $8.1b
Payments Of Lease Liabilities Classified As Financing Activities — $38.0m $45.0m $55.0m $60.0m $60.0m
Payments To Acquire Or Redeem Entitys Shares — — — $38.0m — —
Proceeds From Borrowings Classified As Financing Activities — — — — $1.2b $46.0m
Purchase Of Intangible Assets Classified As Investing Activities — $70.0m $24.0m $102.0m $68.0m $91.0m
Repayments Of Borrowings Classified As Financing Activities — — $1.5b $553.0m $562.0m $1.4b
Profit after tax $1.2b $1.4b $1.1b $1.1b $1.5b $1.7b
Taxation charge $410.0m $197.0m $499.0m $517.0m $435.0m $472.0m
Net finance costs $7.0m $2.0m $207.0m $368.0m $302.0m $262.0m
Amortisation of intangible assets $90.0m $94.0m $107.0m $108.0m $99.0m $120.0m
Other non-cash movements $100.0m ($22.0m) $24.0m ($11.0m) ($15.0m) ($17.0m)
(Decrease)/increase in pension and other provisions ($27.0m) ($36.0m) ($43.0m) $70.0m $1.0m ($73.0m)
Decrease/(increase) in inventories $130.0m ($17.0m) ($292.0m) ($131.0m) $216.0m $133.0m
(Increase)/decrease in trade receivables $18.0m $14.0m ($85.0m) $38.0m ($312.0m) ($65.0m)
Increase in trade payables $140.0m $41.0m $387.0m $112.0m $158.0m $125.0m
Net change in other receivables and payables ($273.0m) ($190.0m) $171.0m ($126.0m) $144.0m $63.0m
Purchase of intangible assets ($96.0m) ($70.0m) ($24.0m) ($102.0m) ($68.0m) ($91.0m)
Proceeds from sale of intangible assets $924.0m $137.0m $36.0m $246.0m $325.0m —
Proceeds from sale of businesses $221.0m — — — $446.0m $13.0m
Interest received $19.0m $16.0m $19.0m $27.0m $75.0m $60.0m
Payment of lease liabilities ($44.0m) ($38.0m) ($45.0m) ($55.0m) ($60.0m) ($60.0m)
Purchase of non-controlling interests — — — — ($488.0m) ($174.0m)
Distributions to non-controlling interests ($31.0m) ($35.0m) ($48.0m) ($58.0m) ($79.0m) ($11.0m)
Repayment of borrowings ($10.0m) — ($1.5b) ($553.0m) ($562.0m) ($1.4b)
Proceeds from borrowings — $8.0m $11.0b — $1.2b $46.0m
Purchase of shares by employee benefit trust — — — ($38.0m) ($5.0m) —
Purchase of treasury shares — — — — ($116.0m) ($151.0m)
Shares purchased for cancellation — — — — ($503.0m) ($503.0m)
Exchange adjustments ($6.0m) ($4.0m) $15.0m ($15.0m) ($79.0m) ($49.0m)
Overdrafts ($10.0m) ($8.0m) ($73.0m) ($50.0m) ($43.0m) ($21.0m)
Net loss ($2.4m) ($19.6m) — ($106.0m) ($48.6m) ($248.1m)
Stock-based compensation $0 $0 $15.0m $9.2m $9.4m $11.8m
Non-cash lease expense $0 $0 — $1.7m $2.0m $2.1m
Provision (recovery) for credit losses — — — $0 ($996k) $165k
Change in fair value of derivative warrant liabilities $0 $0 — $10.3m ($23.6m) ($3.8m)
Change in fair value on interest rate collar $0 $0 — $106k $0 $0
Change in fair value of contingent consideration liabilities — — — $0 $0 ($861k)
Change in fair value of embedded derivative — — — $0 $0 $144k
Loss on acquisition — — — $0 $0 $6.2m
Gain on sale of trademark — — — $0 $0 ($5.7m)
Accounts receivable ($16.7m) ($5.1m) — ($2.1m) ($3.2m) ($2.7m)
Related party accounts receivable $0 $0 — ($816k) $309k $263k
Inventories $4.4m ($6.0m) — ($1.3m) $2.6m ($867k)
Prepaid expenses ($1.9m) ($1.1m) — $996k ($2.2m) $318k
Other current assets and other assets $1.2m $612k — $138k ($377k) $158k
Accounts payable ($7.4m) $9.6m — $4.4m ($3.0m) ($6.8m)
Related party accounts payable $0 $0 — ($354k) ($18k) $0
Other current liabilities and other liabilities $4.1m $2.5m — $1.7m $1.8m $14.6m
Proceeds from sale of trademark — — — $0 $0 $82.5m
Acquisition of Novaestiq — — — $0 $0 ($2.6m)
Cash received from interest rate collar premium — $0 — $52k $92k $0
Proceeds from PIPE investments $0 $0 — $70.0m $0 $0
Payment of PIPE transaction costs — $0 — ($1.1m) $0 $0
Proceeds from term loan, net of discount $0 $110.0m — $0 $0 $396.1m
Repayment of term loan ($9.4m) ($72.5m) — ($8.8m) ($8.8m) ($405.3m)
Proceeds from revolving credit facility, net of discount $29.0m $20.0m — $35.0m $15.0m $44.3m
Repayment of revolving credit facility ($9.0m) ($44.0m) — ($49.1m) $0 ($60.0m)
Proceeds from note payable — $0 — $2.4m $1.6m $1.5m
Repayment of note payable — $0 — ($1.5m) ($1.8m) ($1.6m)
Distribution to pay withholding taxes — $0 — ($1.2m) $0 $0
Interest $5.4m $10.0m — $17.3m $15.1m $21.4m
Non-cash portion of distribution agreement acquired — — — $0 $0 $29.8m
Capital expenditures in accounts payable and accruals $0 $86k — $318k $146k $219k
Issuance of stock for acquisition $0 $0 — $0 $0 $7.6m
Contingent consideration (Equity classified) — — — $0 $0 $21.9m
Initial measurement of embedded derivatives — — — $0 $0 $12.6m
Accrued but unpaid debt issuance costs — — — $0 $0 $1.0m
Proceeds from trust account $0 $0 — $0 $0 —
Proceeds from FPA investments $0 $0 — $0 $0 —
Income taxes $9k $0 — $0 $0 —
Obagi China Distribution to shareholder $0 $0 — $0 $0 —
Conversion of promissory note to warrants $0 $0 — $0 $0 —
Gain on PPP loan forgiveness $0 ($6.8m) — $0 — —
Loss on write-off of loan receivable $0 $2.6m — $0 — —
Advances for note receivable $0 ($2.5m) — $0 — —
Proceeds from PPP Loan $6.8m $0 — — — —
Capital contribution of trademarks $4.1m $0 — — — —
Beginning Cash Position — — $406.0m $611.0m $994.0m $2.2b
Change In Inventory — — ($292.0m) ($131.0m) $216.0m $133.0m
Change In Other Current Assets — — $171.0m ($126.0m) $144.0m $63.0m
Change In Payable — — $387.0m $112.0m $158.0m $125.0m
Change In Receivables — — ($85.0m) $38.0m ($312.0m) ($65.0m)
Change In Working Capital — — $181.0m ($107.0m) $206.0m $256.0m
Changes In Cash — — $190.0m $398.0m $1.3b ($855.0m)
End Cash Position — — $611.0m $994.0m $2.2b $1.3b
Financing Cash Flow — — $6.9b ($1.6b) ($1.5b) ($3.1b)
Free Cash Flow — — $1.7b $1.8b $2.0b $2.2b
Gain Loss On Investment Securities — — — — ($37.0m) ($43.0m)
Gain Loss On Sale Of Business — — $0 $0 ($121.0m) $0
Gain Loss On Sale Of PPE — — ($30.0m) $12.0m ($7.0m) $0
Interest Received CFI — — $19.0m $27.0m $75.0m $60.0m
Investing Cash Flow — — ($8.8b) ($134.0m) $528.0m ($346.0m)
Net Business Purchase And Sale — — $0 ($71.0m) $446.0m $13.0m
Net Intangibles Purchase And Sale — — $12.0m $144.0m $257.0m ($91.0m)
Net PPE Purchase And Sale — — ($304.0m) ($234.0m) ($250.0m) ($322.0m)
Other Non Cash Items — — $216.0m $357.0m $287.0m $288.0m
Pension And Employee Benefit Expense — — ($43.0m) $70.0m $1.0m ($73.0m)
Purchase Of Business — — $0 ($71.0m) $0 $0
Purchase Of Intangibles — — ($24.0m) ($102.0m) ($68.0m) ($91.0m)
Purchase Of PPE — — ($304.0m) ($234.0m) ($250.0m) ($322.0m)
Repurchase Of Capital Stock — — $0 $0 ($619.0m) ($654.0m)
Sale Of Business — — $0 $0 $446.0m $13.0m
Sale Of Intangibles — — $36.0m $246.0m $325.0m $0
Sale Of PPE — $12.0m $0 $0 — —
Profit or Loss — $1.4b $1.1b $1.1b $1.5b $1.7b
Cash flows from investing activities
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities $6.0m $12.0m ($30.0m) $12.0m ($7.0m) —
Purchase of property, plant and equipment ($222.0m) ($228.0m) ($304.0m) ($234.0m) ($250.0m) ($322.0m)
Capital expenditure on intangible assets ($653k) ($863k) — ($455k) ($304k) ($237k)
Purchase of business, net of cash acquired $20.0m — — ($71.0m) — —
Acquisition of Business Combinations, net of cash acquired $0 $0 — $0 $0 —
Net Investment Purchase And Sale — — $700.0m $0 $0 ($6.0m)
Purchase Of Investment — — — $0 $0 ($6.0m)
Sale Of Investment — $100.0m $700.0m $0 $0 —
Net cash (outflow)/inflow from investing activities $1.0b ($33.0m) ($8.8b) ($134.0m) $528.0m ($346.0m)
Net cash (used in) provided by investing activities ($1.7m) ($3.8m) — ($2.0m) — —
Payment of debt issuance costs ($1.0m) ($6.4m) — $0 $0 ($10.2m)
Issuance Of Debt — — $11.0b $0 $1.2b $46.0m
Long Term Debt Issuance — — $11.0b $0 $1.2b $46.0m
Net Issuance Payments Of Debt — — $9.5b ($553.0m) $652.0m ($1.3b)
Net Long Term Debt Issuance — — $9.5b ($553.0m) $652.0m ($1.3b)
Payment of debt termination fees — — — $0 $0 ($11.6m)
Long Term Debt Payments — — ($1.5b) ($553.0m) ($562.0m) ($1.4b)
Repayment Of Debt — — ($1.5b) ($553.0m) ($562.0m) ($1.4b)
Net Common Stock Issuance — — $0 $0 ($619.0m) ($654.0m)
Common Stock Payments — — $0 $0 ($619.0m) ($654.0m)
Dividends Paid Ordinary Shares Per Share — $1,148.00 $11,930.00 — — —
Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners — — — $388 $419 $439
Dividends paid to shareholders ($2k) ($1k) ($3k) ($388) ($570) ($612)
Payment of dividends ($2.0m) ($2.0m) — $0 — —
Cash Dividends Paid — — ($2.7b) ($388.0m) ($570.0m) ($612.0m)
Common Stock Dividend Paid — ($1.1b) ($2.7b) ($388.0m) — —
Other financing cash flows — ($12.0m) $345.0m ($72.0m) ($8.0m) $31.0m
Net Other Financing Charges — — $363.0m ($110.0m) ($501.0m) ($143.0m)
Net cash outflow from financing activities ($2.4b) ($1.2b) $6.9b ($1.6b) ($1.5b) ($3.1b)
Net cash (used in) provided by financing activities $14.3m $5.2m — $44.3m $5.6m ($47.2m)
Effect of foreign exchange rates on cash and cash equivalents $0 ($32k) — ($147k) ($116k) ($601k)
Effect Of Exchange Rate Changes — — $15.0m ($15.0m) ($79.0m) ($49.0m)
(Decrease)/Increase in cash and cash equivalents and bank overdrafts — $87.0m $190.0m $398.0m $1.3b ($855.0m)
Cash and cash equivalents and bank overdrafts at the beginning of the period $323.0m $406.0m $611.0m $994.0m $2.2b $1.3b
Cash and cash equivalents $333.0m $414.0m $684.0m $1.0b $2.2b $1.3b
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH $5.2m $4.9m $12.6m ($6.2m) $16.2m
CASH, CASH EQUIVALENTS AND RESTRICTED CASH - Beginning of period $3.4m $8.6m — $10.2m $22.6m $16.3m
Restricted cash — — — $1.5m $1.5m $1.5m
Change In Cash Supplemental As Reported — — $190.0m $398.0m $1.3b ($855.0m)
Interest Paid Classified As Financing Activities ($19.0m) $15.0m $163.0m $404.0m $360.0m $357.0m
Income Taxes Paid Refund Classified As Operating Activities ($554.0m) $310.0m $324.0m $445.0m $593.0m $439.0m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.